Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
NEW YORK--(BUSINESS WIRE)--Rhinix ApS announced today that it is looking for strategic partners to bring Rhinix™, a side effect free alternative to medication for patients with respiratory allergies, into the US market. Rhinix ApS is a privately held company focused on helping patients with respiratory allergies who are not well-controlled by today’s drug options or who wish to get off day-to-day medication. In collaboration with the Trade Council at the Royal Danish Consulate General, Rhinix ApS has begun its efforts to bring Rhinix™ to the US, by looking for a strong strategic partner capable of a nationwide launch of Rhinix™.
Help employers find you! Check out all the jobs and post your resume.
NEW YORK--(BUSINESS WIRE)--Rhinix ApS announced today that it is looking for strategic partners to bring Rhinix™, a side effect free alternative to medication for patients with respiratory allergies, into the US market. Rhinix ApS is a privately held company focused on helping patients with respiratory allergies who are not well-controlled by today’s drug options or who wish to get off day-to-day medication. In collaboration with the Trade Council at the Royal Danish Consulate General, Rhinix ApS has begun its efforts to bring Rhinix™ to the US, by looking for a strong strategic partner capable of a nationwide launch of Rhinix™.
Help employers find you! Check out all the jobs and post your resume.
